trisequens has been researched along with raloxifene hydrochloride in 1 studies
| Studies (trisequens) | Trials (trisequens) | Recent Studies (post-2010) (trisequens) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
|---|---|---|---|---|---|
| 56 | 35 | 1 | 2,818 | 481 | 810 |
| Protein | Taxonomy | trisequens (IC50) | raloxifene hydrochloride (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0053 | |
| Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacchi Modena, A; Baldini, M; Benassi, L; Dei Cas, A; Luciana Barilli, A; Manotti, C; Rinaldi, M; Sgarabotto, M | 1 |
1 trial(s) available for trisequens and raloxifene hydrochloride
| Article | Year |
|---|---|
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Topics: Aged; Body Mass Index; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors | 2007 |